WeSearch

Nearly 10% AxSpA Patients Meet Difficult-to-Manage Criteria

·2 min read · 0 reactions · 0 comments · 37 views
#health#research#disease
Nearly 10% AxSpA Patients Meet Difficult-to-Manage Criteria
TL;DR · WeSearch summary

A recent study found that 9.1% of patients with axial spondyloarthritis (axSpA) meet the criteria for difficult-to-manage disease. Among these, 2.2% were classified as having treatment-refractory axSpA. The study highlights the need for integrated care approaches due to the complexity of managing these patients.

Key facts
About this source

Medscape files mainly under health. We currently carry 231 of its stories.

Original article
Medscape
Read full at Medscape →
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherMedscape
Canonical URLhttps://www.medscape.com/viewarticle/nearly-10-patients-axspa-meet-criteria-difficult-manage-2026a1000ifj?src=rss
Publication timeWed, 3 Jun 2026 01:11:22 EDT
Retrieval time2026-06-03T05:41:56.797Z
Last seen2026-06-03T05:41:56.797Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterffL8_O6bs4Jc
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

TOPLINE:Among patients with axial spondyloarthritis (axSpA), 9.1% fulfilled the criteria for difficult-to-manage (D2M) disease, with 2.2% meeting the criteria for treatment-refractory disease. Higher spinal pain scores and fibromyalgia were independently linked to D2M axSpA.METHODOLOGY:Researchers performed a cross-sectional analysis of prospectively collected data to determine the prevalence of D2M axSpA and identify associated factors in 536 patients with axSpA (median age, 48 years; 66% male) who attended follow-up visits between May 2024 and May 2025 at an institute in Toronto, Ontario, Canada.The Assessment of SpondyloArthritis International Society (ASAS) definitions for D2M and treatment-refractory disease were applied, with D2M defined as treatment failure with at least two…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from Medscape